For one patient in a recent study on terminal cancer in Aotearoa New Zealand, a sudden onset of breathlessness felt like a clear warning sign. Given her history of breast cancer, the symptom was alarming. However, her general practitioner viewed the situation through a different lens, attributing the respiratory distress to the patient’s history of mental health struggles. Instead of a referral to an oncologist, she was prescribed an antidepressant.
The breathlessness did not subside. It was only after repeated visits and an eventual trip to the emergency department that the truth emerged: the cancer had metastasized to her lungs. This sequence of events highlights a precarious tension in modern medicine. While doctors are trained to be stewards of limited healthcare resources, the line between prudent resource management and a dangerous diagnostic delay is often thin and inconsistently drawn.
At the heart of this issue is the dual role physicians play: acting as either “gatekeepers” or “brokers.” While these roles may seem like two sides of the same professional coin, the decision of which role to adopt for a specific patient can determine who receives life-extending treatment and who is left to navigate a failing system alone. For those living with life-limiting diseases, these discretionary decisions are not merely administrative—they are existential.
As a physician, I have seen how the pressure to avoid “over-testing” can inadvertently lead to “under-diagnosing.” When a doctor acts as a gatekeeper, their primary goal is efficiency—ensuring that scarce specialist appointments and expensive diagnostic tools are reserved for those who truly need them. But when that gate closes too firmly, the result is a systemic failure that often falls hardest on the most vulnerable.
The Hidden Lottery of Medical Brokering
While gatekeeping is designed to protect the system, “brokering” is an act of advocacy. A broker is a physician who uses their professional capital, connections, or discretion to bypass standard hurdles for a patient. In many cases, this is seen as a benevolent act of “going to bat” for someone who has been let down by the system.
The research reveals a troubling pattern: the decision to broker access is often based on an implicit assessment of who is “worthy” of extra effort. This “worthiness” is rarely based on clinical need alone. Instead, it often aligns with social capital and systemic privilege. For example, the study noted a medical professional who was among only 100 people in New Zealand to receive an unsubsidized medication at no cost. Similarly, a patient in their 30s was placed on multiple melanoma trials despite not meeting the strict trial protocols.
This creates a tiered system of care where access is dictated by a patient’s professional status, age, or the doctor’s personal empathy. When a specialist works to get a patient onto a vaccine trial to compensate for a previous misdiagnosis, they are correcting a mistake. However, when that same advocacy is unavailable to those without the right connections, the “broker” role inadvertently reinforces a healthcare lottery.
| Doctor’s Role | Primary Objective | Potential Positive Outcome | Potential Negative Outcome |
|---|---|---|---|
| Gatekeeper | Resource Efficiency | Avoids unnecessary interventions | Dangerous diagnostic delays |
| Broker | Patient Advocacy | Access to cutting-edge trials/drugs | Inequitable distribution of care |
| Boundary Enforcer | Clinical Standard | Ensures evidence-based practice | Exclusion of cultural/spiritual needs |
Structural Inequity and the Māori Experience
In Aotearoa, these dynamics are not neutral; they are overlaid onto a history of structural inequity. For Māori, the roles of gatekeeper and broker can exacerbate existing health disparities. Gatekeeping, even when not intentionally malicious, often reproduces a pattern of later diagnosis and poorer outcomes that Māori already face at higher rates than non-Māori patients.
the study suggests that Māori patients are less likely to possess the specific types of social or professional capital that make a patient “broker-worthy” in the eyes of the system. If the act of brokering—pushing for a trial, securing an unsubsidized drug, or challenging a protocol—remains informal and discretionary, it risks cementing the very inequities that public health policies nominally aim to reduce.
Beyond the access to medicine, there is the role of the “boundary enforcer.” Some practitioners act as guards of Western evidence-based medicine, dismissing or ignoring alternative approaches to healing. For some Māori patients, this rigidity creates a cultural chasm. When doctors refuse to acknowledge the spiritual or cultural dimensions of cancer care, patients may conclude that the medical establishment is unable or unwilling to understand their world, leading some to reject Western medicine entirely.
The High Cost of Discretionary Care
The tension between these roles is most visible in the hospital sector, where the stakes are highest. The research highlighted a devastating example of gatekeeping gone wrong: a patient with a terminal brain tumour was sent home and told that further treatment would be a “waste of time.” It took the relentless tenacity of the patient’s spouse to force the system to reconsider and provide possible treatment.
This underscores the danger of “clinical judgment” when it is used to withhold resources without a transparent, evidence-based framework. When a doctor decides a treatment is a “waste,” they are no longer just managing resources; they are making a value judgment on the patient’s remaining quality of life.
To move toward a more equitable system, the medical community must transition from being gatekeepers and brokers to being “bridge builders.” This requires a systemic shift where advocacy is not a favor granted to a privileged few, but a standard of care provided to all. Understanding the subconscious drivers behind why a doctor chooses to broker for one patient but gatekeep for another is the first step in dismantling these invisible barriers.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The next step in addressing these disparities involves the ongoing analysis of practitioner decision-making processes within New Zealand’s health system. As Te Whatu Ora (Health New Zealand) continues to integrate services, researchers are looking for ways to standardize referral pathways to ensure that “worthiness” is replaced by clinical necessity and equity.
Do you believe healthcare access is too dependent on the individual doctor’s advocacy? Share your thoughts in the comments or share this story to join the conversation on health equity.
